These findings suggest that direct binding of SARS-CoV-2 to ACE2 on pancreatic β-cells might contribute to their damage (Figure 1) and subsequent insulin deficiency and hyperglycemia, as observed previously in patients with SARS-CoV infection [28]. The gene discussed is ACE2; the disease is Hyperglycemia.